The Role of Biomarker Testing in Patients with Myelofibrosis

Dr Naveen Pemmaraju explains the relationship of the JAK/STAT pathway to myelofibrosis and the molecular mutations he looks for with biomarker testing.

EP: 1.An Overview of Myelofibrosis

Now Viewing

EP: 2.The Role of Biomarker Testing in Patients with Myelofibrosis

EP: 3.Current Treatment Options in Myelofibrosis

EP: 4.Study Design and Outcomes of the Phase II REFINE Trial

EP: 5.Potential Implications of the REFINE Trial on the Myelofibrosis Treatment Paradigm

EP: 6.Investigational Agents and Unmet Needs in Myelofibrosis Treatment

Recent Videos